dual PDE 10/PDE 2 inhibitors (biocrea)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Namedual PDE 10/PDE 2 inhibitors (biocrea)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionType 2 cyclic nucleotide phosphodiesterases inhibitorsPhosphodiesterase 10A inhibitors

TargetsType 2 cyclic nucleotide phosphodiesterasesPhosphodiesterase 10A

Therapy Area/IndicationsSchizophreniaAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBioCrea GmbH

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBioCrea GmbH

Active IndicationsN/A

Inactive IndicationsSchizophreniaAlzheimer Disease

ATC CodeN/A